The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Screening of SirT1 activating compounds and their cytotoxicity in prostate cancer cell lines.
Maofu Fu
No relevant relationships to disclose
Nagarajan Pattabiraman
No relevant relationships to disclose
Chenguang Wang
No relevant relationships to disclose
Xiaoming Ju
No relevant relationships to disclose
Anthony Sauve
No relevant relationships to disclose
Richard G. Pestell
No relevant relationships to disclose